Van Der Heijden

Michiel Van der Heijden

Targeted cancer therapy

This research group aims to advance the development of targeted therapies for treating cancer, with a specific focus on bladder cancer. For patients with advanced disease, new therapeutic approaches are urgently needed.

Michiel and his group are searching for novel molecular targets, as well as mechanisms of drug resistance and biomarkers that can guide therapy. Through the large number of bladder cancer patients at the adjacent Antoni van Leeuwenhoek hospital, their discoveries can be rapidly translated into the clinic.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.